Clinical trial to assess the pharmacokinetic characteristics of Lodivixx tab. 5/160mg in healthy male subjects

Trial Profile

Clinical trial to assess the pharmacokinetic characteristics of Lodivixx tab. 5/160mg in healthy male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs Levamlodipine/valsartan (Primary) ; Amlodipine/valsartan
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Acronyms HL-LDV
  • Most Recent Events

    • 25 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top